These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2524856)

  • 1. Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat.
    Dugovic C; Wauquier A; Leysen JE; Marrannes R; Janssen PA
    Psychopharmacology (Berl); 1989; 97(4):436-42. PubMed ID: 2524856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT2 receptors could be primarily involved in the regulation of slow-wave sleep in the rat.
    Dugovic C; Wauquier A
    Eur J Pharmacol; 1987 May; 137(1):145-6. PubMed ID: 2956115
    [No Abstract]   [Full Text] [Related]  

  • 3. Melatonin modulates the sensitivity of 5-hydroxytryptamine-2 receptor-mediated sleep-wakefulness regulation in the rat.
    Dugovic C; Leysen JE; Wauquier A
    Neurosci Lett; 1989 Oct; 104(3):320-5. PubMed ID: 2510097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The light-dark cycle modulates the effects of ritanserin on sleep-wakefulness patterns in the rat.
    Dugovic C; Leysen JE; Janssen PF; Wauquier A
    Pharmacol Biochem Behav; 1989 Nov; 34(3):533-7. PubMed ID: 2516324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
    Backus LI; Sharp T; Grahame-Smith DG
    Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ritanserin and chlordiazepoxide on sleep-wakefulness alterations in rats following chronic cocaine treatment.
    Dugovic C; Meert TF; Ashton D; Clincke GH
    Psychopharmacology (Berl); 1992; 108(3):263-70. PubMed ID: 1523277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT1-like receptor agonists enhance wakefulness.
    Dzoljic MR; Ukponmwan OE; Saxena PR
    Neuropharmacology; 1992 Jul; 31(7):623-33. PubMed ID: 1407402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.
    De Souza RJ; Goodwin GM; Green AR; Heal DJ
    Br J Pharmacol; 1986 Oct; 89(2):377-84. PubMed ID: 2946344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).
    Glennon RA
    Pharmacol Biochem Behav; 1986 Jul; 25(1):135-9. PubMed ID: 2944129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin excitation of facial motoneurons: receptor subtype characterization.
    Rasmussen K; Aghajanian GK
    Synapse; 1990; 5(4):324-32. PubMed ID: 2360199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion.
    Di Renzo G; Amoroso S; Taglialatela M; Canzoniero L; Basile V; Fatatis A; Annunziato L
    Eur J Pharmacol; 1989 Mar; 162(2):371-3. PubMed ID: 2524399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
    Bagdy G; Sved AF; Murphy DL; Szemeredi K
    Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of selective serotonin (5-HT) agonists and 5-HT2 antagonist on prolactin secretion.
    Van de Kar LD; Lorens SA; Urban JH; Bethea CL
    Neuropharmacology; 1989 Mar; 28(3):299-305. PubMed ID: 2524677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor subtypes mediating facilitation by serotonin of excitability of spinal motoneurons.
    Jackson DA; White SR
    Neuropharmacology; 1990 Sep; 29(9):787-97. PubMed ID: 2149874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic 5-HT2 receptor antagonist treatment alters 5-HT1A autoregulatory control of 5-HT release in rat brain in vivo.
    Kidd EJ; Leysen JE; Marsden CA
    J Neurosci Methods; 1990 Sep; 34(1-3):91-8. PubMed ID: 1701842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of different serotonergic receptors in the long-lasting blood pressure depression following muscle stimulation in the spontaneously hypertensive rat.
    Hoffmann P; Carlsson S; Skarphedinsson JO; Thorén P
    Acta Physiol Scand; 1990 Jun; 139(2):305-10. PubMed ID: 2142373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW; Ogilvie J; Houghton AK
    Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs.
    Jäkälä P; Sirviö J; Koivisto E; Björklund M; Kaukua J; Riekkinen P
    Eur J Pharmacol; 1995 Aug; 282(1-3):39-55. PubMed ID: 7498288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.